| 1 |
28034675 | CRISPR/Cas9 mediated sequential editing of genes critical for ookinete motility in Plasmodium yoelii. | 2017 Mar |
1 |
| 2 |
28387831 | Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity. | 2017 Jul 1 |
1 |
| 3 |
26223587 | Absence of a gene encoding cytosine deaminase in the genome of the agaricomycete Coprinopsis cinerea enables simple marker recycling through 5-fluorocytosine counterselection. | 2015 Aug |
1 |
| 4 |
22076044 | Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation. | 2012 Mar |
2 |
| 5 |
22208667 | Role of glutamate 64 in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase. | 2012 Jan 10 |
3 |
| 6 |
22426744 | Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties. | 2012 Jun |
4 |
| 7 |
22547150 | Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression. | 2012 Sep |
2 |
| 8 |
22892453 | Targeted tumor therapy with a fusion protein of an antiangiogenic human recombinant scFv and yeast cytosine deaminase. | 2012 Sep |
1 |
| 9 |
18291415 | Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine. | 2008 Mar 28 |
3 |
| 10 |
18783590 | Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from yeast. | 2008 Sep 10 |
2 |
| 11 |
17394949 | Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro. | 2007 Apr 1 |
2 |
| 12 |
17545615 | Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model. | 2007 Jun 1 |
2 |
| 13 |
16845689 | Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. | 2006 Jul 15 |
1 |
| 14 |
15823054 | Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase. | 2005 Apr 19 |
1 |
| 15 |
16088873 | Cytosine deaminase MX cassettes as positive/negative selectable markers in Saccharomyces cerevisiae. | 2005 Jul 30 |
2 |
| 16 |
15509509 | The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. | 2004 Nov |
2 |
| 17 |
12566311 | Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model. | 2003 Feb 1 |
1 |
| 18 |
12777821 | Crystallization and preliminary crystallographic analysis of yeast cytosine deaminase. | 2003 May |
1 |
| 19 |
11454690 | Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. | 2001 Jul 15 |
2 |
| 20 |
9000374 | Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. | 1997 Jan |
3 |